Is NewAmsterdam Pharma Company N.V. (NAMS) a Buy, Sell, or Hold?
NASDAQ : NAMS
NewAmsterdam Pharma Company N.V.
$31.3058 USD
-$0.67 (-2.11%)
- Volume
- 738.1K
- Average Volume
- 1.28M
- Market Capitalization
- $3.66B
- P/E Ratio
- -17.30
- Dividend Yield
- 0.00%
- Price Target
- $48.00
- Year High
- $42.21
- Year Low
- $20.53
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $9.76
NAMS vs. The Competition
| Properties | NAMS | ACLX | AKRO | CGON |
|---|---|---|---|---|
| Market Cap | $3.66B | $6.73B | $4.5B | $6.18B |
| Shares Outstanding | $116.9M | $58.51M | $82.32M | $88.2M |
| P/E Ratio | -17.3 | -28.27 | -19.87 | -29.97 |
| EPS | -1.76 | -4.07 | -2.72 | -2.21 |
| Day Low | 31.05 | 115.03 | 54.52 | 69.6956 |
| Day high | 33.225 | 115.07 | 54.65 | 72.515 |
| Year Low | 20.529 | 50.85 | 21.34 | 23.65 |
| Year High | 42.205 | 115.13 | 58.4 | 77 |
| Average Price 50 | 33.5262 | 112.6244 | 53.0613 | 65.3644 |
| Average Price 200 | 33.95543 | 84.1487 | 48.19307 | 54.94828 |
| Volume | 738.1K | 13.19M | 11.61M | 197.37K |
| Average Volume | - | - | - | - |